Medical and Pharmaceutical Lung cancer screening awareness remains low despite advances in early detection The 2026 Lung Health Barometer found only 33 per cent of adults knew low-dose CT screening is available for high-risk people Joseph Morton3 days ago
Medical and Pharmaceutical Stand Up To Cancer charity funds non-invasive lung cancer screening projects It will provide up to US$200K for each of the three initiatives Rowan DunneJuly 29, 2026
AI and Autonomy Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform The acquisition targets a cancer monitoring market that the companies estimate could reach USD$20 billion Joseph MortonJuly 29, 2026
AI and Autonomy TidalSense raises USD$19M to expand AI-powered COPD diagnostic platform The investment comes as Britain's healthcare system struggles to diagnose COPD quickly Joseph MortonJuly 28, 2026
Health & Wellness Swiss breathalyser proves its worth as weight loss measurement tool It is nearly as accurate as a mass spectrometer Rowan DunneJuly 27, 2026
Medical and Pharmaceutical Medtech investment firm NovoMed PARTNERS launches in California Its founders' oversaw CathWorks' US$585M takeover by Medtronic Rowan DunneJuly 24, 2026
Medical and Pharmaceutical Cizzle Biotech rises 16% from U.S. launch of lung cancer blood test The CIZ1B test is meant to complement LDCT in detecting early-stage disease Rowan DunneJuly 23, 2026
Medical and Pharmaceutical Cancer detection specialist Freenome lists on Nasdaq through special purpose merger Freenome has been developing its blood biopsy platform for more than a decade Rowan DunneJuly 20, 2026
Medical and Pharmaceutical Study explores possible pesticide connection to lung cancer in younger non-smokers Researchers stressed that the study does not suggest healthy foods cause lung cancer Joseph MortonJuly 17, 2026
AI and Autonomy Robotic lung biopsy system brings earlier cancer detection closer to patients Lung cancer remains the leading cause of cancer deaths worldwide Joseph MortonJuly 15, 2026